CIERRA O'NEAL: Open Payments
NPI 1346787231 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 45 payments from 21 companies in 2025. Trend: 2023 $705 · 2024 $815 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $163 |
| Novo Nordisk Inc | 8 | $141 |
| Abbott Laboratories | 3 | $67 |
| Stryker Corporation | 2 | $51 |
| Dynavax Technologies Corporation | 2 | $51 |
| ABBVIE INC. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Zimmer Biomet Holdings, Inc. | 1 | $40 |
| Lilly USA, LLC | 1 | $34 |
| Exact Sciences Corporation | 2 | $30 |
Products named: FARXIGA, Wegovy, BREZTRI, FREESTYLE LIBRE 3, Ozempic, JARDIANCE, Heplisav-B, XIFAXAN.
Industry payments across SC — which companies pay providers there.
